[1] M. van Slegtenhorst, M. Nellist, B. Nagelkerken, J. Cheadle, R. Snell, A. van den Ouweland, A. Reuser, J. Sampson, D. Halley, P. van der Sluijs, Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products, Human Molecular Genetics 7 (1998) 1053-1057. 10.1093/hmg/7.6.1053.
[2] K. Inoki, Y. Li, T. Xu, K.L. Guan, Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling, Genes Dev 17 (2003) 1829-1834. 10.1101/gad.1110003.
[3] E.P. Henske, S. Jóźwiak, J.C. Kingswood, J.R. Sampson, E.A. Thiele, Tuberous sclerosis complex, Nat Rev Dis Primers 2 (2016) 16035. 10.1038/nrdp.2016.35.
[4] R. Ekong, M. Nellist, M. Hoogeveen-Westerveld, M. Wentink, J. Panzer, S. Sparagana, W. Emmett, N.L. Dawson, M.C. Malinge, R. Nabbout, C. Carbonara, M. Barberis, S. Padovan, M. Futema, V. Plagnol, S.E. Humphries, N. Migone, S. Povey, Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis, Hum Mutat 37 (2016) 364-370. 10.1002/humu.22951.
[5] J. Huang, B.D. Manning, The TSC1-TSC2 complex: a molecular switchboard controlling cell growth, Biochem J 412 (2008) 179-190. 10.1042/bj20080281.
[6] B.D. Manning, A.R. Tee, M.N. Logsdon, J. Blenis, L.C. Cantley, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3- kinase/akt pathway, Mol Cell 10 (2002) 151-162. 10.1016/s1097-2765(02)00568-3.
[7] K. Inoki, Y. Li, T.Q. Zhu, J. Wu, K.L. Guan, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling, Nature Cell Biology 4 (2002) 648-657. 10.1038/ncb839.
[8] K. Inoki, T. Zhu, K.L. Guan, TSC2 mediates cellular energy response to control cell growth and survival, Cell 115 (2003) 577-590. 10.1016/s0092-8674(03)00929-2.
[9] J.J. Howell, K. Hellberg, M. Turner, G. Talbott, M.J. Kolar, D.S. Ross, G. Hoxhaj, A. Saghatelian, R.J. Shaw, B.D. Manning, Metformin Inhibits Hepatic mTORC1 Signaling via DoseDependent Mechanisms Involving AMPK and the TSC Complex, Cell Metabolism 25 (2017) 463- 471. 10.1016/j.cmet.2016.12.009.
[10] A. Garcia-Aguilar, C. Guillen, M. Nellist, A. Bartolome, M. Benito, TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy, Biochimica Et Biophysica Acta-Molecular Cell Research 1863 (2016) 2658-2667. 10.1016/j.bbamcr.2016.08.006.
[11] E. Lesma, S.M. Sirchia, S. Ancona, S. Carelli, S. Bosari, F. Ghelma, E. Montanari, A.M. Di Giulio, A. Gorio, The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells, Am J Pathol 174 (2009) 2150-2159. 10.2353/ajpath.2009.080799.
[12] K. Yamagata, H. Daitoku, Y. Takahashi, K. Namiki, K. Hisatake, K. Kako, H. Mukai, Y. Kasuya, A. Fukamizu, Arginine Methylation of FOXO Transcription Factors Inhibits Their Phosphorylation by Akt, Molecular Cell 32 (2008) 221-231. 10.1016/j.molcel.2008.09.013.
[13] S. Jahan, J.R. Davie, Protein arginine methyltransferases (PRMTs): role in chromatin organization, Adv Biol Regul 57 (2015) 173-184. 10.1016/j.jbior.2014.09.003.
[14] R.S. Blanc, S. Richard, Arginine Methylation: The Coming of Age, Molecular Cell 65 (2017) 8-24. 10.1016/j.molcel.2016.11.003.
[15] H. Wei, R. Mundade, K.C. Lange, T. Lu, Protein arginine methylation of non-histone proteins and its role in diseases, Cell Cycle 13 (2014) 32-41. 10.4161/cc.27353.
[16] H.S. Han, D. Choi, S. Choi, S.H. Koo, Roles of protein arginine methyltransferases in the control of glucose metabolism, Endocrinol Metab (Seoul) 29 (2014) 435-440. 10.3803/EnM.2014.29.4.435.
[17] W.K. Paik, D.C. Paik, S. Kim, Historical review: the field of protein methylation, Trends Biochem Sci 32 (2007) 146-152. 10.1016/j.tibs.2007.01.006.
[18] W.J. Lin, J.D. Gary, M.C. Yang, S. Clarke, H.R. Herschman, The mammalian immediateearly TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase, J Biol Chem 271 (1996) 15034-15044. 10.1074/jbc.271.25.15034.
[19] T.M. Lakowski, A. Frankel, Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4, Biochem J 421 (2009) 253-261. 10.1042/BJ20090268.
[20] J. Najbauer, B.A. Johnson, A.L. Young, D.W. Aswad, Peptides with sequences similar to glycine, arginine-rich motifs in proteins interacting with RNA are efficiently recognized by methyltransferase(s) modifying arginine in numerous proteins, J Biol Chem 268 (1993) 10501- 10509.
[21] M.R. Pawlak, C.A. Scherer, J. Chen, M.J. Roshon, H.E. Ruley, Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable, Mol Cell Biol 20 (2000) 4859-4869. 10.1128/mcb.20.13.4859-4869.2000.
[22] L. Ganesh, T. Yoshimoto, N.C. Moorthy, W. Akahata, M. Boehm, E.G. Nabel, G.J. Nabel, Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis, Mol Cell Biol 26 (2006) 3864-3874. 10.1128/MCB.26.10.3864-3874.2006.
[23] S. Gayatri, M.W. Cowles, V. Vemulapalli, D.H. Cheng, Z.W. Sun, M.T. Bedford, Using oriented peptide array libraries to evaluate methylarginine-specific antibodies and arginine methyltransferase substrate motifs, Scientific Reports 6 (2016) 28718. 10.1038/srep28718.
[24] W. Xu, H. Cho, S. Kadam, E.M. Banayo, S. Anderson, J.R. Yates, B.M. Emerson, R.M. Evans, A methylation-mediator complex in hormone signaling, Genes Dev 18 (2004) 144-156. 10.1101/gad.1141704.
[25] K. Higashimoto, P. Kuhn, D. Desai, X. Cheng, W. Xu, Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1, Proc Natl Acad Sci U S A 104 (2007) 12318-12323. 10.1073/pnas.0610792104.
[26] M.T. Bedford, S.G. Clarke, Protein Arginine Methylation in Mammals: Who, What, and Why, Molecular Cell 33 (2009) 1-13. 10.1016/j.molcel.2008.12.013.
[27] H. Wang, Z.Q. Huang, L. Xia, Q. Feng, H. Erdjument-Bromage, B.D. Strahl, S.D. Briggs, C.D. Allis, J. Wong, P. Tempst, Y. Zhang, Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor, Science 293 (2001) 853-857. 10.1126/science.1060781.
[28] E.M. Michalak, J.E. Visvader, Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?, Mol Oncol 10 (2016) 1497-1515. 10.1016/j.molonc.2016.09.003.
[29] M. Chen, X.S. Qu, Z.Q. Zhang, H.Y. Wu, X. Qin, F.J. Li, Z.F. Liu, L.Y. Tian, J.H. Miao, W. Shu, Cross-talk between Arg methylation and Ser phosphorylation modulates apoptosis signalregulating kinase 1 activation in endothelial cells, Molecular Biology of the Cell 27 (2016) 1358- 1366. 10.1091/mbc.E15-10-0738.
[30] Y. Li, K. Inoki, K.L. Guan, Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity, Molecular and Cellular Biology 24 (2004) 7965-7975. 10.1128/mcb.24.18.7965-7975.2004.
[31] D.R. Plas, C.B. Thompson, Akt activation promotes degradation of tuberin and FOXO3a via the proteasome, Journal of Biological Chemistry 278 (2003) 12361-12366. 10.1074/jbc.M213069200.
[32] X. Gu, J.M. Orozco, R.A. Saxton, K.J. Condon, G.Y. Liu, P.A. Krawczyk, S.M. Scaria, J.W. Harper, S.P. Gygi, D.M. Sabatini, SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway, Science 358 (2017) 813-818. 10.1126/science.aao3265.
[33] T. Shiga, T. Kawata, T. Furusho, T. Tadokoro, T. Suzuki, Y. Yamamoto, Elevation of urinary methylmolonic acid induces the suppression of megalin-mediated endocytotic cycles during vitamin B12 deficiency, Biochem Biophys Res Commun 465 (2015) 206-212. 10.1016/j.bbrc.2015.07.151.
[34] O.D. Maddocks, C.F. Labuschagne, P.D. Adams, K.H. Vousden, Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells, Mol Cell 61 (2016) 210-221. 10.1016/j.molcel.2015.12.014.
[35] X. Gao, S.M. Sanderson, Z. Dai, M.A. Reid, D.E. Cooper, M. Lu, J.P. Richie, A. Ciccarella, A. Calcagnotto, P.G. Mikhael, S.J. Mentch, J. Liu, G. Ables, D.G. Kirsch, D.S. Hsu, S.N. Nichenametla, J.W. Locasale, Dietary methionine influences therapy in mouse cancer models and alters human metabolism, Nature 572 (2019) 397-401. 10.1038/s41586-019-1437-3.
[36] D. Musiani, J. Bok, E. Massignani, L. Wu, T. Tabaglio, M.R. Ippolito, A. Cuomo, U. Ozbek, H. Zorgati, U. Ghoshdastider, R.C. Robinson, E. Guccione, T. Bonaldi, Proteomics profiling of arginine methylation defines PRMT5 substrate specificity, Sci Signal 12 (2019). 10.1126/scisignal.aat8388.
[37] S. Gen, Y. Matsumoto, K.I. Kobayashi, T. Suzuki, J. Inoue, Y. Yamamoto, Stability of tuberous sclerosis complex 2 is controlled by methylation at R1457 and R1459, Sci Rep 10 (2020) 21160. 10.1038/s41598-020-78274-6.
[38] S. Gen, Y. Matsumoto, T. Suzuki, J. Inoue, Y. Yamamoto, Methionine controls insulin/mammalian target of rapamycin complex 1 activity by modulating tuberous sclerosis complex 2 stability, Biochem Biophys Res Commun 541 (2021) 84-89. 10.1016/j.bbrc.2021.01.033.